About: Ranirestat

An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Ranirestat (also known as AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and . It has been granted orphan drug status. The drug is to be used orally.

Property	Value
dbo:abstract	Ranirestat (also known as AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and . It has been granted orphan drug status. The drug is to be used orally. (en)
dbo:iupacName	(3R)-2′-[(4-Bromo-2-fluorophenyl)methyl]-1′H-spiro[pyrrolidine-3,4′-pyrrolo[1,2-a]pyrazine]-1′,2,3′,5(2′H)-tetrone (en)
dbo:thumbnail	wiki-commons:Special:FilePath/Ranirestat.svg?width=300
dbo:wikiPageID	12839039 (xsd:integer)
dbo:wikiPageLength	3847 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID	1014324409 (xsd:integer)
dbo:wikiPageWikiLink	dbr:Orphan_drug dbr:Clinical_trial dbr:Dainippon_Sumitomo_Pharma dbr:Tolrestat dbc:Orphan_drugs dbr:Diabetic_neuropathy dbr:Aldose_reductase_inhibitor dbc:Aldose_reductase_inhibitors dbc:Pyrrolopyrazines dbr:Polyol dbr:PharmaKyorin
dbp:imagefile	Ranirestat.svg (en)
dbp:pin	-2 (xsd:integer)
dbp:verifiedfields	changed (en)
dbp:verifiedrevid	449870766 (xsd:integer)
dbp:watchedfields	changed (en)
dbp:wikiPageUsesTemplate	dbt:Gastrointestinal-drug-stub dbt:Chembox dbt:Chembox_Hazards dbt:Chembox_Identifiers dbt:Chembox_Properties dbt:Refimprove dbt:Reflist dbt:Cascite dbt:Chemspidercite dbt:Fdacite dbt:Stdinchicite dbt:Oral_hypoglycemics
dcterms:subject	dbc:Orphan_drugs dbc:Aldose_reductase_inhibitors dbc:Pyrrolopyrazines
gold:hypernym	dbr:Inhibitor
rdf:type	owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q11173 yago:WikicatOrphanDrugs yago:Agent114778436 yago:CausalAgent100007347 yago:Drug103247620 yago:Inhibitor114724436 yago:Matter100020827 yago:PhysicalEntity100001930 dbo:ChemicalCompound dbo:Drug yago:Substance100020090 yago:WikicatAldoseReductaseInhibitors
rdfs:comment	Ranirestat (also known as AS-3201) is an aldose reductase inhibitor being developed for the treatment of diabetic neuropathy by Dainippon Sumitomo Pharma and . It has been granted orphan drug status. The drug is to be used orally. (en)
rdfs:label	Ranirestat (en)
owl:sameAs	freebase:Ranirestat yago-res:Ranirestat wikidata:Ranirestat http://azb.dbpedia.org/resource/رانیرستات dbpedia-fa:Ranirestat dbpedia-sh:Ranirestat dbpedia-sr:Ranirestat https://global.dbpedia.org/id/4tWhU
prov:wasDerivedFrom	wikipedia-en:Ranirestat?oldid=1014324409&ns=0
foaf:depiction	wiki-commons:Special:FilePath/Ranirestat.svg
foaf:isPrimaryTopicOf	wikipedia-en:Ranirestat
is dbo:wikiPageWikiLink of	dbr:Aldose_reductase dbr:Aldose_reductase_inhibitor
is foaf:primaryTopic of	wikipedia-en:Ranirestat